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Accuracy of Intraocular Lens Power Calculation Formulas in 
Primary Angle Closure Glaucoma
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The Catholic University of Korea College of Medicine, Seoul, Korea
Purpose: To compare the accuracy of intraocular lens (IOL) power calculation formulas in eyes with primary angle 
closure glaucoma (ACG). 
Methods: This retrospective study compared the refractive outcomes of 63 eyes with primary ACG with the results 
of 93 eyes with normal open angles undergoing uneventful cataract surgery. Anterior segment biometry including 
anterior chamber depth, axial length, and anterior chamber depth to axial length ratio were compared by the IOL 
Master. Third generation formulas (Hoffer Q and SRK/T) and a fourth generation formula (Haigis) were used to 
predict IOL powers in both groups. The predictive accuracy of the formulas was analyzed by comparison of the 
mean error and the mean absolute error (MAE).
Results: In ACG patients, anterior chamber depth and the anterior chamber depth to axial length ratio were smaller 
than normal controls (all p < 0.05). The MAEs from the ACG group were larger than that from the control group in 
the Haigis formula. The mean absolute error from the Haigis formula was the largest and the mean absolute error 
from the Hoffer Q formula was the smallest.
Conclusions: IOL power prediction may be inaccurate in ACG patients. The Haigis formula produced more in-
accurate results in ACG patients, and it is more appropriate to use the Hoffer Q formula to predict IOL powers in 
eyes with primary ACG. 
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Intraocular lens (IOL) power is determined by 3 factors: 
preoperative biometric data (axial length, anterior chamber 
depth, lens thickness, and keratometric value), the IOL cal-
culation formula, and the IOL constant [1]. Most cataract sur-
geons have applied third-generation formulas; however, 
these formulas have limitations in predicting the position of 
the IOL based on axial length and central corneal power [2]. 
On the other hand, preoperative anterior chamber depth 
(ACD) and lens thickness are taken into consideration in 
fourth-generation formulas [3]. 
Ucakhan et al. [4]. concluded that anterior chamber depth 
increased after uneventful phacoemulsification and IOL im-
plantation, and that a shallower anterior chamber produced a 
greater increase in ACD. After cataract surgery in eyes with 
angle closure glaucoma, declining intraocular pressure and 
deepening of the anterior chamber has been reported [5-7]. 
Some studies have surmised that the IOP lowering effect of 
cataract surgery also induces a decrease in axial length 
[8-10]. This suggests the need for a precise investigation of 
intraocular lens power calculation formula in eyes with angle 
closure glaucoma (ACG). 
In this study, we aimed to compare the accuracy of 2 
third-generation formulas (the Hoffer Q formula and the 
SRK/T formula) and 1 fourth-generation formula (the Haigis 
formula) in ACG patients.
Materials and Methods
This retrospective study included 156 eyes of 156 patients 
who underwent cataract surgery between July 2009 and 
December 2009 in the glaucoma clinics at Yeouido St. 
Mary’s Hospital. Informed consent was obtained from all pa-Korean J Ophthalmol Vol.25, No.6, 2011
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Table 1. Preoperative data in the ACG and the control group 
        ACG group       Control group p-value
*
Eyes          63          93
Age (yr) 59.87 ± 10.55 (40-85) 63.50 ± 10.55 (49-86) 0.358
IOP (mmHg) 16.32 ± 3.71 (12-26) 13.50 ± 2.45 (8-19) 0.002
No. of antiglaucoma medication 1.63 ± 1.19 (0-2) 0 <0.001
UCVA (logMAR) 0.80 ± 0.11 (0.40-2.00) 0.74 ± 0.42 (0.30-1.40) 0.588
BCVA (logMAR) 0.65 ± 0.42 (0.09-2.00) 0.59 ± 0.40 (0.49-1.40) 0.765
Corneal power (D)
†  44.05 ± 1.80 (42.09-47.39)  44.55 ± 1.60 (41.50-48.01) 0.207
AL (mm)
†  23.67 ± 1.03 (21.10-25.53)  24.12 ± 1.67 (21.64-26.67) 0.081
ACD (mm)
† 2.28 ± 0.21 (1.80-2.60) 3.14 ± 0.42 (2.21-4.60) <0.001
ACD/AL ratio
†   0.100 ± 0.018 (0.083-0.113)    0.130 ± 0.019 (0.098-0.188) <0.001
ACG = angle-closure glaucoma; IOP = intraocular pressure; UCVA = uncorrected visual acuity; logMAR = logarithm of the minimum 
angle of resolution; BCVA = best-corrected visual acuity; D = diopter; AL = axial length; ACD = anterior chamber depth.
*p-value by Mann-Whitney U-test.
†Preoperative biometric data (axial length, anterior chamber depth, and corneal power) by the IOL Master.
tients prior to commencement of the study and the study 
methods adhered to the tenets of the Declaration of Helsinki 
for the use of human participants in biomedical research. 
There were 63 eyes diagnosed with primary angle-closure 
glaucoma by a glaucoma specialist (JIM) and all eyes had 
previously undergone laser peripheral iridotomy by the same 
glaucoma specialist. They did not have a history of previous 
ocular surgery, general disorders affecting the cornea, or ocu-
lar disease except ACG. 93 eyes confirmed with normal 
open-angles were also included as a comparative control 
group. All the subjects underwent gonioscopy by a second, 
independent observer (KDK) with extensive experience in 
performing gonioscopy. None of the patients had a history of 
ocular disease, previous ocular surgery, or general disorders 
affecting the cornea in the control group. 
Preoperative IOL power calculations were performed with 
the IOL Master optical biometer ver. 5 (Carl-Zeiss, Jena, 
Germany). The IOL Master uses partial coherence inter-
ferometry to measure axial length. All 156 eyes underwent 
IOL power calculations with the IOL Master optical 
biometer. Corneal power was measured by automated kera-
tometry, which was performed first because the system re-
quires the input of corneal radii to calculate the anterior 
chamber depth. The ACD was determined by calculating the 
distance along the visual axis between the corneal epithelium 
and the lens using lateral slit illumination with high reso-
lution, (±0.01 mm) [11], high precision(≤5 μm) and good re-
liability [12,13].
After preoperative measurements, all of the patients under-
went cataract surgery through a 2.2 mm micro-coaxial 
incision. All procedures were performed by the same surgeon 
(HSK) using the Ozil torsional handpiece with the Infiniti 
Vision System (Alcon, Fort Worth, TX, USA). Local anes-
thesia was administered using topical 4% lidocaine and 0.5% 
proparacaine hydrochloride (Alcaine, Alcon). Surgery was 
performed through a self-sealing, temporal clear corneal 
incision. In this case series, we only included the eyes that 
underwent cataract surgery with no complications in con-
tinuous curvelinear capsulorrhexis. Phacoemulsification was 
performed with 100% torsional ultrasound, 350 mmHg vac-
uum, and 35 cc/min aspiration rate. Following phacoemulsi-
fication, the intraocular lens (SN60WF, Alcon) was inserted 
into the bag. No intraoperative complications occurred. 
Refractive outcome was measured 3 months postoperatively 
by an auto-refractometer (Canon RK-5; Canon, Tokyo, Japan). 
 In 156 eyes of this study, optimized IOL constants pub-
lished on the User Group for Laser Interference Biometry 
website were used. They were pACD = 5.64 (Hoffer Q), 
A-constant = 119.0 (SRK-T), and a0 = -0.734, a1 = 0.187, a2 
= 0.221. The refractive benefits of personalized IOL con-
stants for each surgeon over optimized IOL constants are not 
clinically meaningful [14].
 The predictive refractive accuracy for each formula was 
analyzed in all eyes. The mean error (ME) was the actual 
postoperative SE minus predicted SE and the mean absolute 
error (MAE) was the average absolute value of the ME. A 
negative ME indicates that the patient had a postoperative re-
fraction that was more myopic than intended, while a pos-
itive ME indicates that the patient had a more hyperopic re-
fraction than intended.  
 Statistical analysis was performed using SPSS ver. 17.0 
(SPSS Inc., Chicago, IL, USA). To determine the significance 
of the ME and MAE between the 3 formulas, Friedman test-
ing was performed, and the total experimental level of sig-
nificance was set at 0.05. Mann-Whitney U-testing was used 
for the comparison between the ACG group and the control 
group in each formula. 
Results
 There were 63 eyes in the ACG group and 93 eyes in the 
control group. The two groups were well balanced overall for 
demographic and baseline ocular characteristics. Table 1 shows 
preoperative clinical data. The mean age was 59.87 ± 10.55 J Joo, et al. IOL Formula in ACG Patients
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Table 2. The mean errors (mean [D], range [D]) with 3 formulas in the ACG and the control groups  
ACG group Control group p-value
*
Hoffer Q formula -0.08 ± 0.67 -0.02 ± 0.57 0.815
-0.98 to 1.05   -1.04 to 1.04
SRK/T formula +0.23 ± 0.69 +0.00 ± 0.61 0.120
-1.06 to 1.42    -0.95 to 1.08
Haigis formula +0.31 ± 0.83 +0.02 ± 0.62 0.098
-1.33 to 1.60    -1.01 to 1.00
p-value
† <0.001 0.059
 D = diopter; ACG = angle-closure glaucoma.
*p-value by Mann-Whitney U-test.
†p-value by Friedman test.
ACG
Control
Fig. 1. Mean error (preoperative target refraction subtracted from 
postoperative refraction) which was produced by the Hoffer Q for-




Fig. 2. Mean error (preoperative target refraction subtracted from 
postoperative refraction) which was produced by the SRK/T for-




Fig. 3. Mean error (preoperative target refraction subtracted from 
postoperative refraction) which was produced by the Haigis formula 
in the angle-closure glaucoma (ACG) group and the control group.
years in the ACG group and, 63.50 ± 10.55 years in the con-
trol group. The mean best-corrected visual acuity (logarithm 
of the minimum angle of resolution) was 0.63 ± 0.42 in the 
ACG group and, 0.59 ± 0.40 in the control group. The pre-
operative corneal power (diopter) was 44.05 ± 1.80 in the 
ACG group and, 44.55 ± 1.60 in the control group. The axial 
length (mm) was 23.67 ± 1.03 in the ACG group and, 24.12 ± 
1.67 in the control group. Eyes with ACG showed significantly 
higher IOP than the control group (p = 0.002). Preoperative 
ACD was significantly shallower (p < 0.001). The ACG 
group also showed a significantly smaller anterior chamber 
depth to axial length (ACD/AL) ratio than the control group 
(p < 0.001). 
 Table 2 and Figs. 1-3 show ME (postoperative refraction- 
target refraction by each formula) in both groups. In the ACG 
group, the Hoffer Q formula showed a negative ME indicat-
ing a more myopic result than intended, while the SRK/T for-
mula and the Haigis formula produced a positive ME, indicating 
a more hyperopic result than intended. There were statisti-
cally significant differences between the 3 formulas (p < 0.001). 
In the control group, which had normal open-angle eyes pre-
operatively, the 3 formulas did not significantly differ from 
each other and the absolute values of ME were less than 0.03 
diopter. The control group produced mean errors closer to 
zero than the ACG group in all of the formulas. 
 Table 3 shows mean absolute errors. The Haigis formula 
produced the highest MAE indicating inaccurate results in 
the ACG group. There were no statistically significant differ-
ences between the 3 formulas both in the ACG group and the 
control group. The MAEs from the ACG group were higher 
than the MAEs from the control group in each formula and 
there was a statistically significant difference in the Haigis 
formula (p = 0.039).  Korean J Ophthalmol Vol.25, No.6, 2011
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Table 3. The mean absolute errors (mean [D], range [D]) with 3 formulas in the ACG and the control groups 
ACG group Control group p-value
*
Hoffer Q formula 0.53 ± 0.39 0.45 ± 0.34 0.076
     0 to 1.05      0 to 1.04
SRK/T formula 0.54 ± 0.47 0.47 ± 0.39 0.075
     0 to 1.42      0 to 1.08
Haigis formula 0.69 ± 0.54 0.46 ± 0.40 0.039
     0 to 1.60      0 to 1.00
p-value
† 0.229 0.477
 D = diopter; ACG = angle-closure glaucoma.
*p-value by Mann-Whitney U-test.
†p-value by Friedman test.
Table 4. The percentage of patients within or outside ±0.5 D of target refraction with 3 formulas in the ACG and the 
control groups
Formula Groups Within ±0.5 D of target 
refraction (%)
Outside ±0.5 D of target 
refraction (%)
Hoffer Q formula ACG group 68.3 31.7
Control group 61.3 38.7
p-value (between %)
*      0.729
SRK/T formula ACG group 55.6 44.4
Control group 63.4 36.6
p-value (between %)
*      0.046
Haigis formula ACG group 49.2 50.8
Control group 69.9 30.1
p-value (between %)
*      0.021
 D = diopter; ACG = angle-closure glaucoma.
*p-value by chi-square test.
 Table 4 shows the percentage of patients within or outside 
±0.5 diopter of the target refraction with 3 formulas in the 
ACG and the control groups. The Hoffer Q formula is stat-
istically insignificant (p = 0.729) in the difference between 
the two (ACG and control) groups, thereby indicating that 
the Hoffer Q formula works as well in the ACG group as in 
the control group. The other two formulas (SRK/T formula 
and Haigis) showed a statistically significant difference (p = 
0.046, p = 0.021, respectively) in the percentage of patients 
between the two groups, which means that the two formulas 
may not be as accurate when applied in the ACG group as in 
the control group. 
Discussion
  The present study demonstrates the possibility of in-
accurate IOL power calculation in eyes with ACG through 
the comparison of IOL formulas. For precise comparison of 
the IOL formulas, we assessed only 1 IOL (Acrysof SN60WF, 
Alcon), because the accuracy of power calculation formulas 
may differ across different IOL types [14,15] and simulta-
neous assessment of several IOLs may prevent accurate eval-
uation of the IOL formula. Furthermore, we excluded cases 
with inappropriate capsulorrhexis that might induce an in-
accurate outcome [2].
 In this study, eyes with ACG produced more unstable re-
sults than normal eyes. Both standard deviations of ME and 
the MAEs were larger in the ACG group. Eyes with ACG 
display a propensity for a higher than normal intracapsular 
volume. This large capsular bag may result in tilting or de-
centering of an intra-capsular IOL and these deviated IOLs 
may cause unstable refraction, postoperatively [16-18].
 Eyes with ACG also showed more hyperopic results than 
intended (0.23 diopter with the SRK/T formula, 0.31 diopter 
with the Haigis formula). The lens plays a pivotal role in the 
pathogenesis of ACG because of its anatomic peculiarities, 
such as increased thickness and relative anterior positioning, 
and because progression of lens thickness causes narrowing 
of the angle [16,17]. Cataract surgery contributes to postoperative 
widening of the angle by completely removing lens volume 
and the pupillary block and this results in deepening of the 
anterior chamber, a subsequent hyperopic shift in ocular 
power occurs when an IOL is implanted in a more posterior 
plane than pre-operatively planned. The Haigis formula pro-
duced the highest MAE (0.69 diopter) and the most hyperopic 
results (ME, +0.31 diopter). The inaccuracy of the Haigis 
formula may be caused by biometric data using ACD. Third- 
generation formulas were aimed at more accurate prediction J Joo, et al. IOL Formula in ACG Patients
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of the position of the IOL, incorporating the effect of corneal 
curvature [18]. Popular formulas for IOL power calculation 
like the SRK/T formula and the Hoffer Q formula are based 
on thin lens optics [19]. In thin lens optics, the cornea and the 
lens (crystalline or IOL) are replaced by infinitely thin lenses 
with 2 refractive powers. However, whereas other formulas 
use only one constant (ACD constant, surgeon factor) for 
IOL power calculation, the Haigis formula, one of the fourth 
generation formulas, uses 3 constants (a0, a1, a2) and pre-
operative ACD is taken into consideration [3]. An increase of 
1 mm ACD will cause a change in the effective lens position 
in the Haigis formula of 0.4 mm, which will be reflected in a 
refractive change of 0.5 to 0.6 diopter [20]. The 3 IOL con-
stants of the Haigis formula followed from a double re-
gression analysis using axial length and ACD and IOL con-
stant optimization and are based on eyes with normal ACD or 
ACD/AL ratio. Therefore, IOL constants from normal eyes 
may induce inaccurate results and underestimate ideal IOL 
power in ACG patients as they have a statistically significant 
shallower ACD and a smaller ACD/AL ratio than normal 
eyes. The previous studies using the IOL Master, the Hoffer 
Q formula has been shown to induce better results than the 
SRK/T formula in hyperopic eyes when AL is less than 22.0 
mm [21,22]. In this study, the ACG group did not show sig-
nificantly shorter axial length than the control group, but 
nonetheless, the Hoffer Q formula produced better results 
than the SRK/T formula (ME, -0.08 diopter vs. +0.23 diopter).
 In conclusion, cataract surgeons must recognize that the 
refractive outcomes may be erroneous depending on which 
IOL formula is applied before cataract surgery and thus the 
IOL power prediction may be inaccurate in ACG patients. 
The Haigis formula, which considers preoperative anterior 
chamber depth for IOL power determination, produced in-
accurate results in eyes with ACG, possibly due to an unusual 
increase of anterior chamber depth after phacoemulsification. 
In those cases, we recommend applying the Hoffer Q for-
mula for the IOL power calculation. 
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